CX Venous Programme 25–28 APRIL 2017, OLYMPIA GRAND, LONDON, UK ORGANISING BOARD: Ian Franklin, Stephen Black, Alun Davies and Andrew Bradbury
Total Page:16
File Type:pdf, Size:1020Kb
Vascular & Endovascular Consensus Update Pathways of Care CONTROVERSIES CHALLENGES CONSENSUS CX Venous Programme 25–28 APRIL 2017, OLYMPIA GRAND, LONDON, UK ORGANISING BOARD: Ian Franklin, Stephen Black, Alun Davies and Andrew Bradbury Peripheral Acute Aortic Venous Arterial Stroke Consensus Consensus Consensus Consensus 25 APRIL 26–27 APRIL 28 APRIL CX Venous Consensus CX Venous Workshop Update – NEW CX Venous Edited CX Venous Abstracts Plenary Programme Cases Register at WWW.CXSYMPOSIUM.COM Early bird registration ends: 26 February 2017 EDUCATION INNOVATION EVIDENCE [email protected] CX Symposium @cxsymposium CX Venous Consensus Update – Plenary Programme 25 April 2017, Lower Main Auditorium Investigations of superficial and deep venous Pelvic vein congestion and reflux anatomy Prevalence of pelvic vein venous reflux and criteria for treatment Kathleen Gibson, Bellevue, United States WHETHER to intervene Prevalence of pelvic vein incompetence in women with chronic pelvic pain The best imaging modality – the implication of cost and influence on quality of life – scoring systems Alun Davies, London, United Kingdom Charles McCollum, Manchester, United Kingdom Computed tomography (CT) venography and magnetic resonance (MR) venography are performed in the horizontal position – suitability for assessing venous function Andrew Wigham, Oxford, United Kingdom Varicose vein management Value of fusion imaging to treat deep venous thrombosis INTERVENTION METHOD and outcomes Adrien Hertault, Lille, France Endovenous adhesive vs. radiofrequency ablation at three years – VeClose study Nick Morrison, Scottsdale, United States The place of ultrasound for deep venous assessment Fabrizio D'Abate, London, United Kingdom Predictors of recanalisation after cyanoacrylate truncal vein treatment Yiu Che Chan, Hong Kong Haemodynamic assessment of venous reflux and obstruction Andrew Nicolaides, London, United Kingdom Biomatrix sclerofoam as a rival for endothermal ablation Johann Christof Ragg, Berlin, Germany WHEN to intervene INTERVENTION METHOD Mechanochemical ablation of varicose veins – present evidence and indications Steve Elias, Englewood, United States Assessment and intervention of acute and chronic Anti-venous thrombosis protocol – new scoring system disease of the deep venous system Isaac Nyamekye, Worcester, United Kingdom Why are so many venous stents deployed for swollen legs? A compression system to improve working compression pressure Lowell Kabnick, New York, United States Torbjorn Lundh, Gothenburg, Sweden Pathways of care for venous stenting interventions Endovenous adhesive occlusion for advanced superficial venous disease – Manj Gohel, Cambridge, United Kingdom WAVES study data at 12 months Kathleen Gibson, Bellevue, United States Best medical and pharmacological treatment for post-thrombotic syndrome TEA Arkadiusz Jawien, Bydgoszcz, Poland Treatment for acute deep venous thrombosis – pathways of care on the use Aesthetic phlebology of catheter-directed thrombolysis and mechanical thrombectomy Rick de Graaf, Maastricht, Netherlands WHETHER to intervene ATTRACT trial – medical treatment versus intervention (catheter-directed WHEN to intervene thrombolysis or mechanical thrombectomy) INTERVENTION METHOD Suresh Vedantham, Saint Louis, United States FOLLOW-UP COFFEE Optimising cosmetic outcomes for reticular veins and telangiectasia Albert-Adrien Ramelet, Montcherand, Switzerland Industry Sponsored Satellite Foam sclerotherapy for reticular veins and telangiectasia See more on www.cxsymposium.com Claudine Hamel-Desnos, Caen, France Patient choice in deploying a deep venous stent Ramon Varcoe, Sydney, Australia Lymphoedema VIVO – EU stent results for symptomatic iliofemoral venous outflow obstruction Narayan Karunanithy, London, United Kingdom WHETHER to intervene Modern understanding of primary lymphatic dysplasias and prognosis Early clot removal and stenting Michael Lichtenberg, Arnsberg, Germany Sahar Mansour, London, United Kingdom Complex endovascular inferior vena cava reconstruction Overview of lymphatic imaging techniques Nils Kucher, Bern, Switzerland John Rasmussen, Houston, United States Cost-effectiveness of intervention for acute and chronic deep vein Surgical procedures for lymphoedema Aina Greig, London, United Kingdom thrombosis Andrew Bradbury, Birmingham, United Kingdom Deep venous stenting for chronic venous disease – stenting of the iliac tract Erin Murphy, Jackson, United States Leg ulceration VERNACULAR iliac venous stent study Rick de Graaf, Maastricht, Netherlands INTERVENTION METHOD and outcomes Use of deep venous stents – flexibility versus strength Modern guidelines for leg ulceration Keith Poskitt, Cheltenham, United Kingdom Stephen Black, London, United Kingdom Biological strategies for wound healing Decision-making in the choice of anticoagulants and length of treatment Muholan Kanapathy, London, United Kingdom following deep venous stenting Adam Gwozdz, London, United Kingdom Pathways of care – early venous reflux ablation (EVRA) Endophlebectomy and fistula – necessity and at what risk Manj Gohel, Cambridge, United Kingdom Houman Jalaie, Aachen, Germany The current role for the use of inferior vena cava filters – indications and contraindications Gerard Goh, Melbourne, Australia LUNCH Industry Sponsored Satellite See more on www.cxsymposium.com Visit hands-on techniques Upper limb/subclavian vein compression Conservative treatment of Paget Schrötter syndrome Kaj Johansen, Seattle, United States Treatment of subclavian vein compression/central veins occlusions Narendra Nath Khanna, New Delhi, India This preliminary CX Venous Programme is subject to change EDUCATION INNOVATION EVIDENCE EDUCATION INNOVATION EVIDENCE For more information visit www.cxsymposium.com or email [email protected] [email protected] CX Symposium @cxsymposium [email protected] CX Symposium @cxsymposium CX Venous Workshop 26–27 April 2017, Venous City (Exhibition level) The CX Venous Workshop is the longest running and one of the largest of its kind in the world. It is part of the four- day CX Venous Programme of the Charing Cross Symposium and expands on the technical aspects of key topics from the CX Venous Main Programme. On days two and three of the CX Symposium, the CX Venous Workshop offers one-to-one demonstrations by world-leading experts on various superficial and deep venous interventions at dedicated training stations including: • Acute DVT imaging and clot ageing • Foam phlebectomy • Steam thermotherapy • Acute DVT interventions • Foam sclerotherapy • Sulodexide for prevention of post- • Acute venous thrombosis • Investigation for occult malignancy thrombotic syndrome – NEW • Aesthetic phlebology after acute DVT • Superficial venous thrombophlebitis • Air plethysmography and • IVUS management haemodynamic assessment of • Labial and pudendal veins • Surgical skills lower limb outflow • Lymphoedema • Surgical deep venous • Ambulatory phlebectomy • Neovalve construction surgery in reconstructions • Caval filters PTS – NEW • Thermal – radiofrequency • CHIVA • Neuromuscular electrical • Thermal – laser • Comparison of CT, MR and IVUS stimulation • Treatment of perforator veins for planning deep vein interventions • Non-thermal ablation • Ultrasound City • Compression techniques – NEW • Paget Schroetter syndrome • Valve technologies • Compression film bandage for foam • Pelvic vein reflux • Vascular ultrasound training sclerotherapy – NEW • Restless leg syndrome – NEW simulator • Deep vein stenting • Ruscus extract for chronic venous • Venous embryology and anatomy • Diagnostic venous ultrasound disease – NEW and virtual reality teaching The comprehensive CX Venous Programme also includes: NEW CX Venous Edited Cases CX Venous Abstracts 26‒27 April 2017, Venous City (Exhibition level) 28 April 2017, CX Learning Centres For the first time, edited cases on venous intervention will Senior and trainee physicians will present over 30 abstracts be presented as part of the CX Venous Programme on days in the venous field. two and three of the CX Symposium. What participants say about the CX Venous Programme 2016 – CME feedback “The CX Venous Programme provides a very good update on the everchanging venous therapies. I will be introducing some into my practice” “I enjoyed the deep venous session. It was well organised, well attended and well debated. This highlights the growing importance of this aspect of vascular surgery” “I really enjoyed the CX Venous Workshop. I found out about the use of the newest devices for superficial and deep venous treatment” This preliminary CX Venous Programme is subject to change EDUCATION INNOVATION EVIDENCE EDUCATION INNOVATION EVIDENCE For more information visit www.cxsymposium.com or email [email protected] [email protected] CX Symposium @cxsymposium [email protected] CX Symposium @cxsymposium Invited CX Venous Programme Faculty Evi Kalodiki, London, UK Constantinos Kyriakides, London, UK Stephen Black, London, UK John Rasmussen, Houston, USA Tristan Lane, London, UK Andrew Bradbury, Birmingham, UK Ramon Varcoe, Sydney, Australia Christopher Lattimer, London, UK Patrick Lintott, High Wycombe, UK Yiu-Che Chan, Hong Kong Suresh Vedantham, Saint Louis, USA Anthony Lopez, London, UK Fabrizio D’Abate, London, UK Andrew Wigham, Oxford, UK Oliver Lyons, London, UK Alun Davies, London, UK Francis Matthey, London, UK Ian Franklin, London, UK Additional CX Vickie McDonald, London, UK Rick de Graaf, Maastricht, Netherlands Andrew McIrvine, London, UK Steve Elias, Englewood, USA Venous